For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease ...
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...
Research presented by Professor Cecilia Johansson of Imperial College London has linked early type I interferon signalling in ...
Investigator-Initiated Preclinical studies at CIC biomaGUNE aimed at combatting Glioblastoma Multiforme Research will evaluate effects of intra-arterial delivery of Annamycin HOUSTON, Dec. 08, 2025 ...
Morning Overview on MSN
An experimental nasal spray could fight lethal brain cancer
Glioblastoma is one of the most lethal brain cancers known, and for decades treatment has barely budged survival curves despite surgery, radiation, and chemotherapy. Now researchers are testing a ...
CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...
The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the Broad Institute that treats non-small cell lung cancer — the most common type ...
The GENEROUS Model aims to reduce Medicaid drug costs by aligning prices with international standards, launching in 2026. It builds on existing programs like the Medicaid Drug Rebate Program and the ...
Glorious is back with one of the most standout gaming mouse launches this year. Rather than pursuing pure performance and an ultra-light weight, the company has instead focused on making a mouse that ...
A small shift in temperature is enough to make a new class of nanoparticles snap together, offering a novel way to deliver fragile medicines. Researchers at the University of Chicago Pritzker School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback